N. Berliner et al., GRANULOCYTE-COLONY-STIMULATING FACTOR INDUCTION OF NORMAL HUMAN BONE-MARROW PROGENITORS RESULTS IN NEUTROPHIL-SPECIFIC GENE-EXPRESSION, Blood, 85(3), 1995, pp. 799-803
We have used a combination of hematopoietic growth factors to induce i
n vitro granulocytic maturation. A fraction of marrow cells enriched f
or hematopoietic progenitor cells (CD34+, HLA-DR+) was isolated from n
ormal human bone marrow by monoclonal antibody staining and fluorescen
ce-activated cell sorting. Cells were cultured in a suspension system
for 3 days in the presence of stem cell factor and interleukin-3 (IL-3
), after which granulocyte colony-stimulating factor (G-CSF) was added
. Cells were harvested daily and analyzed for phenotypic maturation by
morphologic criteria, and total RNA was obtained for analysis of myel
oid gene expression. Maturation was observed to progress to the tate m
etamyelocyte and band stage over a period of 10 to 12 days. Neutrophil
-specific gene expression was assayed by reverse transcription-polymer
ase chain reaction (RT-PCR). Induction with G-CSF resulted in sequenti
al expression of primary and secondary granule proteins, with asynchro
nous expression of primary granule proteins starting from days 1 to 5,
and synchronous expression of lactoferrin and transcobalamin I (secon
dary granule proteins) from days 7 to 8. Interestingly, myeloperoxidas
e (MPO) mRNA expression was easily detected in both the freshly isolat
ed CD34+, HLA-DR+ cells and cells at all subsequent stages of inductio
n. This suggests that MPO mRNA is expressed very early during neutroph
il development, perhaps before the development of significant numbers
of phenotypically recognizable granules. This recapitulation of a prog
ram of sequential expression of primary and secondary granule protein
genes suggests that in vitro marrow culture suspensions to which appro
priate growth factors are added can mimic normal granulocytic maturati
on. This system should provide an important model for the study of neu
trophil-specific gene expression. (C) 1995 by The American Society of
Hematology.